Carcinogenesis in prostate cancer: The role of long non-coding RNAs

Siegel, 2017, CA cancer, J. Clim., 67, 7 Chen, 2004, Molecular determinants of resistance to antiandrogen therapy, Nat. Med., 10, 33, 10.1038/nm972 Waltering, 2009, Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens, Cancer Res., 69, 8141, 10.1158/0008-5472.CAN-09-0919 Antonarakis, 2014, AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer, N. Engl. J. Med., 371, 1028, 10.1056/NEJMoa1315815 Kung, 2013, Long noncoding RNAs: past, present, and future, Genetics, 193, 651, 10.1534/genetics.112.146704 Ma, 2015, LncRNAWiki: harnessing community knowledge in collaborative curation of human long non-coding RNAs, Nucleic Acids Res., 43, D187, 10.1093/nar/gku1167 Rinn, 2012, Genome regulation by long noncoding RNAs, Annu. Rev. Biochem., 81, 145, 10.1146/annurev-biochem-051410-092902 Lee, 2012, Epigenetic regulation by long noncoding RNAs, Science, 338, 1435, 10.1126/science.1231776 Ponting, 2009, Evolution and functions of long noncoding RNAs, Cell, 136, 629, 10.1016/j.cell.2009.02.006 Gibb, 2011, The functional role of long non-coding RNA in human carcinomas, Mol. Cancer, 10, 38, 10.1186/1476-4598-10-38 Prensner, 2011, The emergence of lncRNAs in cancer biology, Canc. Discov., 1, 391, 10.1158/2159-8290.CD-11-0209 Gutschner, 2012, The hallmarks of cancer: a long non-coding RNA point of view, RNA Biol., 9, 703, 10.4161/rna.20481 Walsh, 2014, Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?, Trends Mol. Med., 20, 428, 10.1016/j.molmed.2014.03.005 Zheng, 2016, The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition, Biochem. Biophys. Res. Commun., 480, 508, 10.1016/j.bbrc.2016.08.120 Takayama, 2013, Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer, EMBO J., 32, 1665, 10.1038/emboj.2013.99 Jia, 2016, Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3, Oncotarget, 7, 37868, 10.18632/oncotarget.9350 Yang, 2013, Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion, Nucleic Acids Res., 41, 9688, 10.1093/nar/gkt680 Sakurai, 2015, The lncRNA DRAIC/PCAT29 locus constitutes a tumor-suppressive nexus, Mol. Canc. Res., 13, 828, 10.1158/1541-7786.MCR-15-0016-T Zhao, 2017, Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients, Prostate, 77, 1107, 10.1002/pros.23367 Schneider, 1988, Genes specifically expressed at growth arrest of mammalian cells, Cell, 54, 787, 10.1016/S0092-8674(88)91065-3 Pickard, 2014, Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy, Breast Canc. Res. Treat., 145, 359, 10.1007/s10549-014-2974-y Kino, 2010, Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor, Sci. Signal., 3, ra8, 10.1126/scisignal.2000568 Pickard, 2013, Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines, Biochim. Biophys. Acta, 1832, 1613, 10.1016/j.bbadis.2013.05.005 Yacqub-Usman, 2015, Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells, Prostate, 75, 693, 10.1002/pros.22952 Xue, 2016, LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway, Tumor Biol., 37, 16187, 10.1007/s13277-016-5429-8 Luo, 2017, LncRNA GAS5 inhibits cellular proliferation by targeting P27Kip1, Mol. Canc. Res., 15, 789, 10.1158/1541-7786.MCR-16-0331 Zhang, 2016, Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer, Biomed. Pharmacother., 83, 936, 10.1016/j.biopha.2016.08.013 Zhang, 2015, LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer, Cell Rep., 13, 209, 10.1016/j.celrep.2015.08.069 Li, 2015, Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population, Oncotarget, 6, 14179, 10.18632/oncotarget.3651 Chiyomaru, 2013, Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR, PLoS One, 8, e70372, 10.1371/journal.pone.0070372 Wu, 2017, Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis, OncoTargets Ther., 10, 1843, 10.2147/OTT.S129928 Wang, 2017, LincRNA-p21 suppresses development of human prostate cancer through inhibition of PKM2, Cell Prolif, 50, 10.1111/cpr.12395 Xu, 2016, Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma, Oncol. Rep., 36, 10, 10.3892/or.2016.4791 Wang, 2016, Long non-coding RNA LOC283070 mediates the transition of LNCaP cells into androgen-independent cells possibly via CAMK1D, Am. J. Transl. Res., 8, 5219 Wang, 2016, Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer, Tumor Biol., 37, 9603, 10.1007/s13277-016-4847-y Zhang, 2017, Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer, OncoTargets Ther., 10, 4945, 10.2147/OTT.S138354 Ren, 2013, Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer, J. Urol., 190, 2278 Wang, 2015, LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer, Oncotarget, 6, 41045, 10.18632/oncotarget.5728 Wang, 2017, Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9(R) to suppress enzalutamide-resistant prostate cancer progression, Eur. Urol., 72, 835, 10.1016/j.eururo.2017.04.005 Sebastian, 2015, Cancer-osteoblast interaction reduces Sost expression in osteoblasts and up-regulates lncRNA MALAT1 in prostate cancer, Microarrays (Basel), 4, 503, 10.3390/microarrays4040503 Luo, 2015, Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer, Cell. Physiol. Biochem., 37, 2209, 10.1159/000438577 Zhou, 2007, Activation of p53 by MEG3 non-coding RNA, J. Biol. Chem., 282, 24731, 10.1074/jbc.M702029200 Chakravarty, 2014, The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer, Nat. Commun., 5, 5383, 10.1038/ncomms6383 Schalken, 2003, New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene, Urology, 62, 34, 10.1016/S0090-4295(03)00759-3 Lemos, 2016, PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells, Tumor Biol., 37, 11339, 10.1007/s13277-016-5012-3 Salameh, 2015, PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3, Proc. Natl. Acad. Sci. U. S. A., 112, 8403, 10.1073/pnas.1507882112 He, 2016, Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells, Tumor Biol., 37, 16163, 10.1007/s13277-016-5450-y Ozgur, 2017, PCA3 silencing sensitizes prostate cancer cells to enzalutamide-mediated androgen receptor blockade, Anticancer Res., 37, 3631 Roy, 2011, BRCA1 and BRCA2: different roles in a common pathway of genome protection, Nat. Rev. Canc., 12, 68, 10.1038/nrc3181 Prensner, 2014, PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer, Cancer Res., 74, 1651, 10.1158/0008-5472.CAN-13-3159 Prensner, 2014, The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc, Neoplasia, 16, 900, 10.1016/j.neo.2014.09.001 Xu, 2017, Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer, Biomed. Pharmacother., 95, 1112, 10.1016/j.biopha.2017.09.019 Ylipaa, 2015, Transcriptome sequencing reveals PCAT5 as a novel ERG-regulated long noncoding RNA in prostate cancer, Cancer Res., 75, 4026, 10.1158/0008-5472.CAN-15-0217 Shukla, 2016, Identification and validation of PCAT14 as prognostic biomarker in prostate cancer, Neoplasia, 18, 489, 10.1016/j.neo.2016.07.001 White, 2017, Multi-institutional analysis shows that low PCAT-14 expression associates with poor outcomes in prostate cancer, Eur. Urol., 71, 257, 10.1016/j.eururo.2016.07.012 Crea, 2014, Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer, Oncotarget, 5, 764, 10.18632/oncotarget.1769 Malik, 2014, The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer, Mol. Canc. Res., 12, 1081, 10.1158/1541-7786.MCR-14-0257 Al Aameri, 2017, Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: reversal by resveratrol, PLoS One, 12, e0177198, 10.1371/journal.pone.0177198 Lou, 2000, Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway, Prostate, 42, 239, 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G Yang, 2013, lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs, Nature, 500, 598, 10.1038/nature12451 Prensner, 2014, The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer, Oncotarget, 5, 1434, 10.18632/oncotarget.1846 Parolia, 2015, The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo, Mol. Cancer, 14, 46, 10.1186/s12943-015-0314-4 Zhang, 2016, Regulation of androgen receptor splice variant AR3 by PCGEM1, Oncotarget, 7, 15481, 10.18632/oncotarget.7139 Ho, 2016, Regulation of PCGEM1 by p54/nrb in prostate cancer, Sci. Rep., 6, 34529, 10.1038/srep34529 Hung, 2014, A long noncoding RNA connects c-Myc to tumor metabolism, Proc. Natl. Acad. Sci. U. S. A., 111, 18697, 10.1073/pnas.1415669112 He, 2014, Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells, J. Exp. Clin. Canc. Res., 33, 72, 10.1186/s13046-014-0072-y Cui, 2013, The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor, Urol. Oncol., 31, 1117, 10.1016/j.urolonc.2011.11.030 Fang, 2016, A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression, Canc. Lett., 374, 62, 10.1016/j.canlet.2016.01.033 Jin, 2017, Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer, Oncotarget, 8, 26090, 10.18632/oncotarget.15318 Yang, 2017, PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells, Asian J. Androl., 19, 453, 10.4103/1008-682X.178849 Misawa, 2017, Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells, Canc. Sci., 108, 373, 10.1111/cas.13151 Chung, 2011, Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility, Canc. Sci., 102, 245, 10.1111/j.1349-7006.2010.01737.x Meyer, 2011, A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression, PLoS Genet., 7, e1002165, 10.1371/journal.pgen.1002165 Yang, 2017, LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer, Biosci. Biotechnol. Biochem., 1 Liu, 2016, LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a, Canc. Med., 5, 3512, 10.1002/cam4.900 Mehra, 2014, A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer, Neoplasia, 16, 1121, 10.1016/j.neo.2014.11.006 Mehra, 2016, Overexpression of the long non-coding RNA SChLAP1 independently predicts lethal prostate cancer, Eur. Urol., 70, 549, 10.1016/j.eururo.2015.12.003 Prensner, 2013, The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex, Nat. Genet., 45, 1392, 10.1038/ng.2771 Prensner, 2014, RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1, Lancet Oncol., 15, 1469, 10.1016/S1470-2045(14)71113-1 Lee, 2013, Linking the SWI/SNF complex to prostate cancer, Nat. Genet., 45, 1268, 10.1038/ng.2805 Li, 2018, Long noncoding RNA SChLAP1 accelerates the proliferation and metastasis of prostate cancer via targeting miR-198 and promoting the MAPK1 pathway, Oncol. Res., 26, 131, 10.3727/096504017X14944585873631 Li, 2017, SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer, Biochem. Biophys. Res. Commun., 487, 146, 10.1016/j.bbrc.2017.03.169 Misawa, 2016, Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells, J. Biol. Chem., 291, 17861, 10.1074/jbc.M116.718536 Orfanelli, 2015, Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer, Oncogene, 34, 2094, 10.1038/onc.2014.144 Lavorgna, 2015, Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell, Genom. Data, 3, 4, 10.1016/j.gdata.2014.10.020 Na, 2015, Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway, Int. J. Clin. Exp. Med., 8, 12609 Zhang, 2017, Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer, Am. J. Transl. Res., 9, 366 Wang, 2017, LncRNA UCA1 in anti-cancer drug resistance, Oncotarget, 8, 64638, 10.18632/oncotarget.18344 Lee, 2014, High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients, World J. Surg. Oncol., 12, 232, 10.1186/1477-7819-12-232 Wang, 2016, The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells, Canc. Chemother. Pharmacol., 78, 1025, 10.1007/s00280-016-3158-8 Su, 2017, Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer, Mol. Cancer, 16, 142, 10.1186/s12943-017-0711-y Lukacs, 2010, Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation, Cell Stem Cell, 7, 682, 10.1016/j.stem.2010.11.013 van Leenders, 2007, Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features, Eur. Urol., 52, 455, 10.1016/j.eururo.2006.11.020 Sharma, 2013, The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man, Canc. Cell, 23, 35, 10.1016/j.ccr.2012.11.010 Savagner, 2001, Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition, Bioessays, 23, 912, 10.1002/bies.1132 Voulgari, 2009, Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic, Biochim. Biophys. Acta, 1796, 75 Dave, 2011, Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition, J. Biol. Chem., 286, 12024, 10.1074/jbc.M110.168625 Wels, 2011, Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma, J. Invest. Dermatol., 131, 1877, 10.1038/jid.2011.142 Balk, 2008, AR, the cell cycle, and prostate cancer, Nucl. Recept. Signal., 6, e001, 10.1621/nrs.06001